Natural antioxidants for the prevention of atherosclerosis (Q40950984)

25 September 2017

1 reference

title

Natural antioxidants for the prevention of atherosclerosis (English)

1 reference

25 September 2017

1 reference

Odeh RM

1

1 reference

PubMed ID

8570438

25 September 2017

Cornish LA

series ordinal

2

1 reference

PubMed ID

8570438

25 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

25 September 2017

1 reference

25 September 2017

15

1 reference

25 September 2017

5

1 reference

25 September 2017

648-659

1 reference

Coronary heart disease: genetic aspects

25 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Role of oxidized low density lipoprotein in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Interactions of plasma lipoproteins with endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

In vivo inhibition of foam cell development by probucol in Watanabe rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Effect of Antioxidants on Oxidative Modification of LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Vitamin E: antioxidant activity, biokinetics, and bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Vitamin E consumption and the risk of coronary disease in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Vitamin E consumption and the risk of coronary heart disease in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

beta-Carotene: an unusual type of lipid antioxidant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

The safety of beta-carotene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Antioxidant defenses and lipid peroxidation in human blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Antioxidants in relation to lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Interaction of ascorbate and alpha-tocopherol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Inhibition of oxidation of biomembranes by tocopherol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Safety of high-level vitamin C ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Selenium: Biochemical Role as a Component of Glutathione Peroxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Selenium in human nutrition: Dietary intakes and effects of supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Antioxidant vitamin intakes assessed using a food-frequency questionnaire: correlation with biochemical status in smokers and non-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1995.TB02875.X

10.1002/J.1875-9114.1995.TB02875.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8570438